C-myc and bcl-2 overexpression in HER2-positive breast carcinomas

被引：0
|
作者：
Larson, Alexandra L. [1 ,2 ]
Scholtens, Denise M. [1 ,2 ]
Rosca, Adriana A. [1 ,2 ]
Kaklamani, Virginia [1 ,2 ]
Siziopikou, Kalliopi P. [1 ,2 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Breast Pathol & Med Oncol Sect, Evanston, IL 60208 USA
[2] Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.SABCS14-P6-01-21
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6-01-21
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Co-overexpression of bcl-2 and c-myc in uterine cervix carcinomas and premalignant lesions
    Protrka, Z.
    Arsenijevic, S.
    Dimitrijevic, A.
    Mitrovic, S.
    Stankovic, V.
    Milosavljevic, M.
    Kastratovic, T.
    Djuric, J.
    EUROPEAN JOURNAL OF HISTOCHEMISTRY, 2011, 55 (01): : 44 - 49
  • [2] Overexpression of c-Myc and Bcl-2 during progression and distant metastasis of hormone-treated breast cancer
    Planas-Silva, Maricarmen D.
    Bruggeman, Richard D.
    Grenko, Ronald T.
    Smith, J. S.
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2007, 82 (01) : 85 - 90
  • [3] hTERT regulation by NF-κB and c-myc in irradiated HER2-positive breast cancer cells
    Papanikolaou, Vassilis
    Athanassiou, Evangelos
    Dubos, Stephanie
    Dimou, Ioannis
    Papathanasiou, Ioanna
    Kitsiou-Tzeli, Sofia
    Kappas, Constantin
    Tsezou, Aspasia
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2011, 87 (06) : 609 - 621
  • [4] Subtype-specific prognostic impact of Bcl-2 in HER2-positive and HER2-negative breast cancer
    Kim, Taeyeong
    Lim, Seung Taek
    Choi, Hyang Suk
    Cho, In-Jeong
    Noh, Hany
    Lee, Jong-In
    Han, Airi
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [5] OVEREXPRESSION OF THE C-MYC PROTOONCOGENE CAN INDUCE APOPTOSIS THAT IS INHIBITED BY EXPRESSION OF THE BCL-2 PROTOONCOGENE
    BISSONNETTE, RP
    ESCHEVERRI, F
    GREEN, DR
    FASEB JOURNAL, 1992, 6 (05): : A1619 - A1619
  • [6] Expression of Bcl-2 and amplification of c-myc are frequent in basaloid squamous cell carcinomas of the esophagus
    Sarbia, M
    Loberg, C
    Wolter, M
    Arjumand, J
    Heep, H
    Reifenberger, G
    Gabbert, HE
    AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (04): : 1027 - 1032
  • [7] Bcl-2 is a better therapeutic target than c-Myc, but attacking both could be a more effective treatment strategy for B-cell lymphoma with concurrent Bcl-2 and c-Myc overexpression
    Sasaki, Nana
    Kuroda, Junya
    Nagoshi, Hisao
    Yamamoto, Mio
    Kobayashi, Satoru
    Tsutsumi, Yasuhiko
    Kobayashi, Tsutomu
    Shimura, Yuji
    Matsumoto, Yosuke
    Taki, Tomohiko
    Nishida, Kazuhiro
    Horiike, Shigeo
    Akao, Yukihiro
    Taniwaki, Masafumi
    EXPERIMENTAL HEMATOLOGY, 2011, 39 (08) : 817 - 828
  • [8] Androgen Receptor Expression in HER2-Positive Breast Carcinomas
    Larson, Alexandra
    Helenowski, Irene B.
    Pincus, Jennifer
    Ubago, Julianne M.
    Rosca, Adriana
    Blanco, Luis Z.
    Siziopikou, Kalliopi P.
    MODERN PATHOLOGY, 2016, 29 : 53A - 53A
  • [9] Radiation effects on development of HER2-positive breast carcinomas
    Castiglioni, Fabio
    Terenziani, Monica
    Carcangiu, Maria Luisa
    Miliano, Raffaella
    Aiello, Piera
    Bertola, Lorenzo
    Triulzi, Tiziana
    Gasparini, Patrizia
    Camerini, Tiziana
    Sozzi, Galbriella
    Fossati-Bellani, Franca
    Menard, Sylvie
    Tagliabue, Elda
    CLINICAL CANCER RESEARCH, 2007, 13 (01) : 46 - 51
  • [10] HER2-positive grade 1 invasive carcinomas of the breast
    Lee, Andrew H. S.
    Hodi, Zsolt
    Abbas, Areeg
    Ellis, Ian O.
    Rakha, Emad A.
    HISTOPATHOLOGY, 2025, 86 (02) : 278 - 284
12345